SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 48 filers reported holding SATSUMA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $303,000 | – | 10,535 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alambic Investment Management, L.P. | 20,711 | $81,000 | 0.89% |
| RA Capital Management | 4,681,858 | $18,212,000 | 0.33% |
| Ghost Tree Capital, LLC | 200,000 | $778,000 | 0.22% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,885,939 | $7,336,000 | 0.13% |
| Virtu Financial LLC | 39,062 | $152,000 | 0.03% |
| Quantitative Systematic Strategies LLC | 14,195 | $55,000 | 0.01% |
| Cetera Advisor Networks LLC | 85,000 | $331,000 | 0.01% |
| BAILARD, INC. | 38,600 | $150,000 | 0.01% |
| Chicago Partners Investment Group LLC | 14,081 | $52,000 | 0.01% |
| EXANE DERIVATIVES | 4,078 | $15,863,000 | 0.01% |